Kevin McElwee

Kevin McElwee appears in our data through filings on RepliCel Life Sciences Inc. shares, published by SEDI. We count 5 filings; the first trade dates from 10 August 2016 and the latest from 17 January 2023.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 18 January 2023: a transaction of €42k, in RepliCel Life Sciences Inc. The median gap between a trade and its publication by SEDI is 2 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.